Although the expression of the TRIP6 gene or protein was unchanged by taxane treatment of resistant ovarian cancer cell lines in vitro, the treatment of mice xenografts based on an NCI/ADR-RES model with experimental taxoid SB-T-121606 led to the TRIP6 protein downregulation in vivo. Here, TRIP6 is linked to ovarian carcinoma.